Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate.
Morihara D, Watanabe H, Takata K, Iwashita H, Tsuchiya N, Kunimoto H, Kuno S, Fukunaga A, Yotsumoto K, Tanaka T, Sakurai K, Hirano G, Yokoyama K, Nishizawa S, Yoshikane M, Anan A, Takeyama Y, Kitamura Y, Iwata K, Irie M, Shakado S, Sohda T, Sakisaka S.
Morihara D, et al. Among authors: kunimoto h.
Eur J Gastroenterol Hepatol. 2015 Jan;27(1):55-64. doi: 10.1097/MEG.0000000000000208.
Eur J Gastroenterol Hepatol. 2015.
PMID: 25370853